Cargando…
Antiangiogenic mechanisms and factors in breast cancer treatment
Breast cancer is known to metastasize in its latter stages of existence. The different angiogenic mechanisms and factors that allow for its progression are reviewed in this article. Understanding these mechanisms and factors will allow researchers to design drugs to inhibit angiogenic behaviors and...
Autores principales: | Castañeda-Gill, Jessica M., Vishwanatha, Jamboor K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785777/ https://www.ncbi.nlm.nih.gov/pubmed/27013929 http://dx.doi.org/10.4103/1477-3163.176223 |
Ejemplares similares
-
CRISPR deletion of MIEN1 in breast cancer cells
por: Van Treuren, Timothy, et al.
Publicado: (2018) -
Role of Anti-Cancer Peptides as Immunomodulatory Agents: Potential and Design Strategy
por: Tripathi, Amit Kumar, et al.
Publicado: (2022) -
Breast cancer disparities: Frontline strategies, proceedings of the 7(th) annual texas conference on health disparities
por: Kpetemey, Marilyne, et al.
Publicado: (2012) -
Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer
por: Gibbs, Lee D., et al.
Publicado: (2017) -
Antiangiogenic therapy for breast cancer
por: Nielsen, Dorte Lisbet, et al.
Publicado: (2010)